Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology
- PMID:14592862
- DOI: 10.1196/annals.1254.007
Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology
Abstract
There are fetal and adult subtypes of muscle nicotinic receptors (AChRs), whose structures and functional roles are reasonably well known. Mutations of their subunits cause congenital myasthenic syndromes. An autoimmune response to them causes myasthenia gravis (MG). The main immunogenic region (MIR) on muscle AChRs accounts for many aspects of the pathological mechanisms by which the autoimmune response impairs neuromuscular transmission. There are many other AChR subtypes, each defined by a different combination of subunits, some of which are transiently expressed in muscle during development, others of which are expressed in keratinocytes, vascular and bronchial epithelia, and other nonneuronal cells, as well as in a wide variety of neurons. Their varied structures and functional roles are much less well known. Mutations in subunits of some of these AChRs have thus far been associated with rare forms of epilepsy and dysautonomia, but other genetic diseases associated with them probably remain to be discovered. Autoimmune responses to some of these subunits are associated with rare dysautonomias and a skin disease. The pathological mechanisms by which these autoimmune responses impair function are much less well known than in the case of MG. AChRs may provide useful drug targets in several neurological diseases. By far, the biggest direct medical impact of AChRs is addiction to tobacco, which is mediated by nicotine acting on a variety of neuronal AChRs.
Similar articles
- Nicotinic acetylcholine receptors in health and disease.Lindstrom J.Lindstrom J.Mol Neurobiol. 1997 Oct;15(2):193-222. doi: 10.1007/BF02740634.Mol Neurobiol. 1997.PMID:9396010Review.
- Acetylcholine receptors and myasthenia.Lindstrom JM.Lindstrom JM.Muscle Nerve. 2000 Apr;23(4):453-77. doi: 10.1002/(sici)1097-4598(200004)23:4<453::aid-mus3>3.0.co;2-o.Muscle Nerve. 2000.PMID:10716755Review.
- Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors.Luo J, Lindstrom J.Luo J, et al.Autoimmunity. 2012 May;45(3):245-52. doi: 10.3109/08916934.2011.622015. Epub 2011 Oct 21.Autoimmunity. 2012.PMID:21950318Free PMC article.
- Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.Navaneetham D, Penn A, Howard J Jr, Conti-Fine BM.Navaneetham D, et al.Cell Mol Biol (Noisy-le-grand). 1997 May;43(3):433-42.Cell Mol Biol (Noisy-le-grand). 1997.PMID:9193799
- Expression of human AChR extracellular domain mutants with improved characteristics.Lazaridis K, Zisimopoulou P, Giastas P, Bitzopoulou K, Evangelakou P, Sideri A, Tzartos SJ.Lazaridis K, et al.Int J Biol Macromol. 2014 Feb;63:210-7. doi: 10.1016/j.ijbiomac.2013.11.003. Epub 2013 Nov 15.Int J Biol Macromol. 2014.PMID:24246999
Cited by
- Muscle channelopathies and critical points in functional and genetic studies.Jurkat-Rott K, Lehmann-Horn F.Jurkat-Rott K, et al.J Clin Invest. 2005 Aug;115(8):2000-9. doi: 10.1172/JCI25525.J Clin Invest. 2005.PMID:16075040Free PMC article.Review.
- Naturally-expressed nicotinic acetylcholine receptor subtypes.Wu J, Lukas RJ.Wu J, et al.Biochem Pharmacol. 2011 Oct 15;82(8):800-7. doi: 10.1016/j.bcp.2011.07.067. Epub 2011 Jul 20.Biochem Pharmacol. 2011.PMID:21787755Free PMC article.Review.
- Expression of acetylcholine receptors in the brain of mice at the presymptomatic stage of Parkinson's disease.Kryukova EV, Shelukhina IV, Kozina EA, Ugryumov MV, Tsetlin VI.Kryukova EV, et al.Dokl Biochem Biophys. 2013 Mar-Apr;449:69-71. doi: 10.1134/S1607672913020038. Epub 2013 May 9.Dokl Biochem Biophys. 2013.PMID:23657649No abstract available.
- A gating mechanism proposed from a simulation of a human alpha7 nicotinic acetylcholine receptor.Law RJ, Henchman RH, McCammon JA.Law RJ, et al.Proc Natl Acad Sci U S A. 2005 May 10;102(19):6813-8. doi: 10.1073/pnas.0407739102. Epub 2005 Apr 27.Proc Natl Acad Sci U S A. 2005.PMID:15857954Free PMC article.
- Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.Fabiani C, Antollini SS.Fabiani C, et al.Front Cell Neurosci. 2019 Jul 18;13:309. doi: 10.3389/fncel.2019.00309. eCollection 2019.Front Cell Neurosci. 2019.PMID:31379503Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical